Conclusions

Eclampsia is an obstetrical emergency occurring in around 4—5 per 10,000 live births. Both the fetus and the mother are at immediate risk for death or life-long neurologic disability. The ultimate goals of management should be safety of the mother first, and then delivery of a live newborn in optimal condition. Delivery is the only effective treatment. With prompt and effective management and in the absence of cerebrovascular hemorrhage, maternal prognosis is good. Fetal prognosis is dependent largely on gestational age at delivery. The recurrence rate for pre-eclampsia in subsequent pregnancies is reported to be 12—68%, and approximately 10% of these women will experience an eclamptic seizure in a future pregnancy. Magnesium sulfate is the drug of choice for the prevention of the primary as well as recurrent eclamptic seizures.

REFERENCES

Alexander, J. M., Bloom, S. L., McIntire, D.D. and Leveno, K.J. (1999). Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? Obstet. Gynecol., 93, 485-8. American College of Obstetricians and Gynecologists. (1996). Hypertension in Pregnancy. Technical Bulletin No. 219. Washington, DC: ACOG. American College of Obstetricians and Gynecologists. (2002). Diagnosis and Management of Preeclampsia and Eclampsia. Practice Bulletin No. 33. Washington, DC: ACOG.

American College of Obstetricians and Gynecologists. (1999). Induction of Labor. Practice Bulletin No. 10. Washington, DC: ACOG. Apollon, K.M., Robinson, J.N., Schwartz, R.B. and Norwitz, E. R. (2000). Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet. Gynecol., 95, 1017-19. Belfort, M.A. and Moise, K.J. Jr. (1992). Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am. J. Obstet. Gynecol., 167, 661-6. Belfort, M.A., Saade, G.R., Moise, K.J. Jr., et al. (1994). Nimodipine in the management of preeclampsia: maternal and fetal effects. Am. J. Obstet. Gynecol., 171, 417-24.

Belfort, M.A., Tooke-Miller, C., Allen, J.C. Jr., et al. (2001). Changes in flow velocity, resistance indices, and cerebral perfusion pressure in the maternal middle cerebral artery distribution during normal pregnancy. Acta Obstet. Gynecol. Scand., SC, 104—12.

Belfort, M.A., Varner, M.W., Dizon-Townson, D.S., Grunewald, C. and Nisell, H. (2002). Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in pre-eclampsia: a new hypothesis. Am. J. Obstet. Gynecol., 187, 626—34.

Belfort, M. A., Anthony, J., Saade, G. R., Allen, J. C. Jr., et al. for the Nimodipine Study Group. (2003). A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N. Engl. J. Med., S4S, 304—11.

Brosens, I.A., Robertson, W.B. and Dixon, H.G. (1972). The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu., i, 177—91.

Brown, C. E., Purdy, P. and Cunningham, F. G. (1988). Head computed tomographic scans in women with eclampsia. Am. J. Obstet. Gynecol., 159, 915—20.

Chesley, L.C., Annitto, J.E. and Cosgrove, R.A. (1976). The remote prognosis of eclamptic women. Am. J. Obstet. Gynecol., 124, 446—59.

Coetzee, E.J., Dommisse, J. and Anthony, J. (1998). A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe preeclampsia. Br. J. Obstet. Gynae-col., 105, 300—3.

Conde-Agudelo, A. and Kafury-Goeta, A.C. (1997). Case-control study of risk factors for complicated eclampsia. Obstet. Gynecol., 9C, 172—5.

Crawford, S., Varner, M. W., Digre, K. B., Servais, G. and Corbett, J. J. (1987). Cranial magnetic resonance imaging in eclampsia. Obstet. Gynecol., 70, 474—7.

Cross, J.C., Werb, Z. and Fisher, S.J. (1994). Implantation and the placenta: key pieces of the development puzzle. Science, 266, 1508—18.

Delgado-Escueta, A. V., Wasterlain, C., Treiman, D. M. and Porter, R. S. (1982). Current concepts in neurology: management of status epilepticus. N. Engl. J. Med., SC6, 1337—40.

Dierckx, I. and Appel, B. (1989). MR findings in eclampsia. Am. J. Neuroradiol., 10, 445.

Digre, K. B., Varner, M. W., Osborn, A. G. and Crawford, S. (1993). Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch. Neurol., 5C, 399—406.

Douglas, K.A. and Redman, C.W.G. (1994). Eclampsia in the United Kingdom. Br. Med. J., SC9, 1395—400.

Duley, L. (1992). Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia,

Latin America and the Caribbean. Br. J. Obstet. Gynaecol., 99, 547-53.

Duley, L. and Gulmezoglu, A. M. (2001). Magnesium sulphate versus lytic cocktail for eclampsia (Cochrane Review). Cochrane Database Syst. Rev., 1, CD002960.

Fredriksson, K., Lindvall, O., Ingemarsson, I., Astedt, B., Cronqvist, S. and Holtas, S. (1989). Repeated cranial computed tomographic and magnetic resonance imaging scans in two cases of eclampsia. Stroke, 20, 547-53.

Gerthoffer, W.T., Shafer, P.G. and Taylor, S. (1987). Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery. J. Cardiovasc. Pharmacol., 10, 9-15.

Goldstein, D.P. and Berkowitz, R. S. (1994). Current management of complete and partial molar pregnancy. J. Reprod. Med., 39, 139-46.

Hall, D.R., Odendaal, H.J. and Smith, M. (2000). Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour? Br. J. Obstet. Gynaecol., 107, 903-8.

Lindenstrom, E., Boysen, G. and Nyboe, J. (1995). Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am. J. Epidemiol., 142, 1279-90.

Livingston, J. C., Livingston, L. W., Ramsey, R., etal. (2003). Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet. Gynecol., 101, 217-20.

Lopez-Llera, M. (1992). Main clinical types and subtypes of eclampsia. Am. J. Obstet. Gynecol., 166, 4-9.

Lubarsky, S. L., Barton, J. R., Friedman, S. A., Nasreddine, S., Ramadan, M.K. and Sibai, B.M. (1994). Late postpartum eclampsia revisited. Obstet. Gynecol., 83, 502-5.

Lucas, M. J., Leveno, K. J. and Cunningham, F. G. (1995). A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia. N. Engl. J. Med., 333, 201-5.

Magee, L. A., Ornstein, M. P. and von Dadelszen, P. (1999). Fortnightly review: management of hypertension in pregnancy. Br. Med. J., 318, 1332-6.

Maynard, S.E., Min, J.Y., Merchan, J., etal. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest., 111, 600-2.

Meekins, J.W., Pijnenborg, R., Hanssens, M., McFadyen, I. R. and van Asshe, A. (1994). A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol., 101, 669 -74. Miles, J.F. Jr., Martin, J.N. Jr., Blake, P.G., et al. (1990). Postpartum eclampsia: a recurring perinatal dilemma. Obstet. Gynecol., 76, 328-31. Moller, B. and Lindmark, G. (1986). Eclampsia in Sweden,

1976-1980. Acta Obstet. Gynecol. Scand., 65, 307-14. Naidu, K., Moodley, J., Corr, P. and Hoffmann, M. (1997). Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br. J. Obstet. Gynaecol., 104, 1165-72.

Nassar, A.H., Adra, A.M., Chakhtoura, N., et al. (1998). Severe preeclampsia remote from term: labor induction or elective Cesarean delivery? Am. J. Obstet. Gynecol., 179, 1210-13.

Paul, R.H., Koh, K.S. and Bernstein, S.G. (1978). Changes in fetal heart rate-uterine contraction patterns associated with eclampsia. Am. J. Obstet. Gynecol., 130, 165-9.

Prichard, J. A., Cunningham, F. G. and Prichard, S. A. (1984). The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am. J. Obstet. Gynecol., 148, 951-63. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. (2000). Am. J. Obstet. Gynecol., 183(Suppl.), 1-22.

Roberts, J. M. (1995). Magnesium for preeclampsia and eclampsia. N. Engl. J. Med., 333, 250-1. Roberts, J.M., Villar, J. and Arulkumaran, S. (2002). Preventing and treating eclamptic seizures. Br. Med. J., 325, 609-10.

Rochat, R. W., Koonin, L. M., Atrash, H. F., Jewett, J. F. and the Maternal Mortality Collaborative Study Group. (1988). Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet. Gynecol., 72, 91-7. Royburt, M., Seidman, D. S., Serr, D. M. and Mashiach, S. (1991). Neurologic involvement in hypertensive disease of pregnancy. Obstet. Gynecol. Surv., 46, 656-64. Salerni, A., Wald, S. and Flanagan, M. (1988). Relationship among cortical ischemia, infarction, and hemorrhage in eclampsia. Neurology, 22, 408-10. Schwartz, R.B., Janes, K.M., Kalina, P., et al. (1992). Hypertensive encephalopathy: findings on CT., MR imaging, and SPECT imaging in 14 cases. Am. J. Roentgenol., 159, 379-83.

Sheehan, H.L. and Lynch, J.B. (1973). Pathology of Toxemia of Pregnancy. Baltimore: Williams & Wilkins.

Sheth, S.S. and Chalmers, I. (2002). Magnesium for preventing and treating eclampsia: time for international action. Lancet, 359, 1872-3.

Sibai, B. M. (1990). Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am. J. Obstet. Gynecol., 163, 1049-54.

Sibai, B. M. (1996). Treatment of hypertension in pregnant women. N. Engl. J. Med., 335, 257-65.

Sibai, B. M., Lipshitz, J., Anderson, G. D. and Dilts, P. V. Jr. (1981a). Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet. Gynecol., 57, 199-202.

Sibai, B. M., McCubbin, J. H., Anderson, G. D., Lipshitz, J. and Dilts, P.V. Jr. (1981b). Eclampsia. I. Observations from sixty-seven recent cases. Obstet. Gynecol., 58, 609-13.

Sibai, B. M., Taslimi, M. M., el-Nazer, A., Amon, E., Mabie, B.C. and Ryan, G.M. (1986a). Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am. J. Obstet. Gynecol., 155, 501-9.

Sibai, B.M., el-Nazer, A. and Gonzalez-Ruiz, A. (1986b). Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am. J. Obstet. Gynecol., 155, 1011-16.

Sibai, B.M., Abdella, T.N., Spinnato, J.A., et al. (1986c). Eclampsia. V. The incidence of nonpreventable eclampsia. Am. J. Obstet. Gynecol., 154, 581-6.

Sibai, B. M., Mabie, B. C., Harvey, C. J. and Gonzalez, A. R. (1987). Pulmonary edema in severe preeclampsia-eclampsia: analysis of thirty-seven consecutive cases. Am. J. Obstet. Gynecol., 156, 1174-9.

Sibai, B.M., Villar, M.A. and Marbie, B.C. (1990). Acute renal failure in hypertensive disorders of pregnancy: pregnancy outcome and remote prognosis in thirty-one consecutive cases. Am. J. Obstet. Gynecol., 162, 777-83.

Sibai, B. M., Mercer, B. and Sarinoglu, C. (1991). Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am. J. Obstet. Gynecol., 165, 1408-12.

Sibai, B. M., Sarinoglu, C. and Mercer, B. M. (1992). Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am. J. Obstet. Gynecol., 166, 1757-61.

Sibai, B. M. and Ramadan, M. K. (1993a). Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am. J. Obstet. Gynecol., lOB, 1682-90.

Sibai, B. M., Mercer, B. M., Schiff, E. and Friedman, S. A.

(1994). Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am. J. Obstet. Gynecol., lll, 818-22.

Sibai, B. M., Ramadan, M. K., Usta, I., Salama, M., Mercer, B.M. and Friedman, S.A. (1993b). Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol., lO9, 1000-6.

Sibai, B. M., Ramadan, M. K., Chari, R. S. and Friedman, S.A. (1995). Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am. J. Obstet. Gynecol., ll2, 125-9.

The Eclampsia Trial Collaborative Group. (1995). Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet, S4S, 1455-63.

The Magpie Trial. (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet, SS9, 1877-90.

Trommer, B.L., Homer, D. and Mikhael, M.A. (1988). Cerebral vasospasm and eclampsia. Stroke, l9, 326-9.

van Gijn, J. and Rinkel, G.J. (2001). Subarachnoid haemorrhage: diagnosis, causes and management. Brain, l24, 249-78.

von Dadelszen, P., Ornstein, M. P., Bull, S. B., Logan, A. G., Koren, G. and Magee, L. A. (2000). Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet, SSS, 87-92.

Wallace, D. H., Leveno, K. J., Cunningham, F. G., et al.

(1995). Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet. Gynecol., BO, 193-9.

Will, A.D., Lewis, K.L., Hinshaw, D.B. Jr., et al. (1987). Cerebral vasoconstriction in toxemia. Neurology, Sl, 1555-7.

Williams, K. and Galerneau, F. (2003). Maternal trans-cranial Doppler in pre-eclampsia and eclampsia. Ultrasound Obstet. Gynecol., 2l, 507-13.

Williams, K.P. and Wilson, S. (1999). Persistence of cerebral hemodynamic changes in patients with eclampsia: a report of three cases. Am. J. Obstet. Gynecol., 181, 1162-5. Witlin, A.G. and Sibai, B.M. (1998). Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet. Gynecol., 92, 883-9. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.

(1988). Geographic variation in the incidence of hypertension in pregnancy. Am. J. Obstet. Gynecol., 158, 80-3.

Zunker, P., Georgiadis, A. L., Czech, N., Golombeck, K., Brossmann, J. and Deuschl, G. (2003). Impaired cerebral glucose metabolism in eclampsia: a new finding in two cases. Fetal Diagn. Ther., 18, 41-6.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook


Post a comment